1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • October 2014
  • -
  • Frost & Sullivan
  • -
  • 171 pages

The key to Transforming Future of Diagnostic and Therapeutic Medicine

This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is covered into four broad segments, namely by products, by technology and by application. The study covers various areas of interest such as regulatory policies within stem cell research, key business updates, analysis of risk factors, and strategic recommendations. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global stem cell market have been included.

Key Findings
-The global market for stem cell was $ billion in 2013 and is expected to reach $ billion in 2018, growing at a robust CAGR of% from 2013 to 2018.
-The worldwide market for adult stem cell is estimated to be at $billion in 2013 and is projected to reach $ billion by 2018. Adult stem cells constitute % of the total stem cell market.
-Cord blood banking is one of the fastest growing segments of the stem cell market. The number of active cord blood banks worldwide have grown from mere in 2005 to over in 2013.
-North America’s total stem cell market was valued at $ billion in 2013 and is projected to increase to $ billion by 2018.
-The European stem cell market was valued at $billion in 2013 and is projected to increase to $billion by 2018.
-The Asia-Pacific (APAC) stem cell market was valued at $ billion in 2013 and is projected to increase to $billion by 2018.
-APAC countries are progressing fast in the field of various stem cells research, including human embryonic stem cells, induced pluripotent stem cell (IPSc) and others. The major hurdle has been the regulatory environment in these countries, but that has been changing lately. Several Asian countries have modified their regulations regarding stem cell research to attract more investors.
-India, Singapore and South Korea are the frontrunners and are expected to dominate the APAC stem cells market in the coming years. Favourable regulatory changes and funding support from governments have helped the commercialization of the stem cells industry.
-Indian stem cell market was estimated to be $ million in 2013 and is expected to grow at a CAGR of % from 2013 to 2018.
-Current penetration of stem cell banking in Singapore is % and is expected to grow at a CAGR of % in next years.
-South Korea is all set to lead the stem cell research in APAC. Funding in stem cell in this country could be compared to that of US.
-Stem cells obtained from adult organisms constitute the main focus of research and the ethics surrounding the use of these cells are quite undisputed. Therapies employing adult stem cells are being developed by various companies (such as ViaCell, StemSource, Osiris Therapeutics, Neural Stem, and Angioblast) and are moving fast from laboratory to the clinical application phase.
-Majority of companies pursuing stem cell therapeutics are engaged in the development of adult stem cells derived from sources such as bone marrow, neural tissue, adipose tissue, menstrual blood, and placenta.

Table Of Contents

Analysis of the Global Stem Cell Market
1. EXECUTIVE SUMMARY

Executive Summary
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO's Perspective
New Market Opportunities
Key Companies to Watch
Three Big Predictions

2. MARKET OVERVIEW

Market Overview
Definition—Key Terminology
Stem Cell Market Overview
Porter's 5 Forces Analysis
Recent Developments in Stem Cell Research

3. MARKET SEGMENTATION

Market Segmentation
Stem Cell Market Segmentation

4. MARKET SEGMENTATION BY PRODUCTS

Market Segmentation by Products
Adult Stem Cells—Mesenchymal Stem Cells
Mesenchymal Stem Cells—Market Overview
Mesenchymal Stem Cells—Clinical Applications
Adult Stem Cells—Hematopoietic Stem Cells
Adult Stem Cells—Neural Stem Cells
Adult Stem Cells—Umbilical Cord Stem Cells
Adult Stem Cells—Induced Pluripotent Stem Cells (iPSC)
Human Embryonic Stem Cells

5. MARKET SEGMENTATION BY TECHNOLOGY

Market Segmentation by Technology
Cell Acquisition Technique
Cell Production Technique

6. MARKET SEGMENTATION BY APPLICATION

Market Segmentation by Application
Stem Cells by Application
Stem Cells by Application—Key Findings

7. REGULATORY SCENARIO AND POLICIES

Regulatory Scenario and Policies
Global Stem Cell Policies
Global Stem Cell Regulations

8. COMPETITIVE PLAYBOOK

Competitive Playbook
Key Stakeholders
Merger, Acquisition, and Partnership Assessment

9. PROFILE OF THE COMPANIES

Profile of the Companies
Advanced Cell Technology, Inc.
Aldagen, Inc.
Athersys, Inc.
Cellerant Therapeutics, Inc.

10. DRIVERS AND RESTRAINTS—TOTAL STEM CELL MARKET

Drivers and Restraints—Total Stem Cell Market
Global Key Drivers Summary
Global Key Drivers Explained
Global Key Restraints Summary
Global Key Restraints Explained

11. FORECASTS AND TRENDS—TOTAL STEM CELL MARKET

Forecasts and Trends—Total Stem Cell Market
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast Discussion
Global Market Perspective

12. GLOBAL STEM CELL MARKET SEGMENT ANALYSIS

Global Stem Cell Market Segment Analysis
Market Segmentation
Umbilical Cord Blood Stem Cells—Revenue Forecast
Induced Pluripotent Stem Cells—Revenue Forecast
Induced Pluripotent Stem Cells—Revenue Forecast Discussion

13. MARKET SIZE AND FORECASTS BY GEOGRAPHY—NORTH AMERICA

Market Size and Forecasts by Geography—North America
North America—Revenue Forecast
Revenue Forecast Discussion

14. EUROPE

Europe
Europe—Revenue Forecast
Revenue Forecast Discussion
15. ASIA-PACIFIC

Asia-Pacific
Asia-Pacific—Revenue Forecast
Revenue Forecast Discussion

16. ASIA-PACIFIC REGION ANALYSIS—INDIA

Asia-Pacific Region Analysis—India
Indian Stem Cell Market Overview
Indian Stem Cell Banking Market Overview
Indian Stem Cell Transplant Market Overview
Regulations and Policies on Stem Cell in India
Stem Cell Funding in India
India Stem Cell Competitive Overview
India Key Drivers Summary
India Key Restraints Summary
New Market Opportunities in India
Merger, Acquisition and Partnership Assessment

17. AUSTRALIA

Australia
Australia Stem Cell Market Overview
Australia Stem Cell Banking Market Overview
Regulations and Policies on Stem Cell in Australia
Stem Cell Funding in Australia
Australia Stem Cell Competitive Overview
Australia Key Drivers Summary
Australia Key Restraints Summary
New Market Opportunities in Australia
Recent Developments in Stem Cell Research in Australia

18. THAILAND

Thailand
Thailand Stem Cell Market Overview
Thailand Stem Cell Banking Market Overview
Thailand Stem Cell Transplant Market Overview
Regulations and Policies on Stem Cell in Thailand
Stem Cell Funding in Thailand
Thailand Stem Cell Competitive Overview
Thailand Key Drivers Summary
Thailand Key Restraints Summary
New Market Opportunities in Thailand
Recent Developments in Stem Cell Research in Thailand

19. SINGAPORE

Singapore
Singapore Stem Cell Market Overview
Singapore Stem Cell Banking Market Overview
Singapore Stem Cell Transplant Market Overview
Regulations and Policies on Stem Cell in Singapore
Stem Cell Funding in Singapore
Singapore Stem Cell Competitive Overview
Singapore Key Drivers Summary
Singapore Key Restraints Summary
New Market Opportunities in Singapore
Recent Developments in Stem Cell Research in Singapore

20. SOUTH KOREA

South Korea
South Korean Stem Cell Market Overview
South Korean Stem Cell Banking Market Overview
Regulations and Policies on Stem Cell in South Korea
Stem Cell Funding in South Korea
South Korea Stem Cell Competitive Overview
South Korea One of the Few to Introduce Stem Cell Products in Therapeutics
South Korea Key Drivers Summary
South Korea Key Restraints Summary
New Market Opportunities in South Korea
Recent Developments in Stem Cell Research in South Korea

21. MALAYSIA

Malaysia
Malaysian Stem Cell Market Overview
Malaysian Stem Cell Banking Market Overview
Malaysia Stem Cell Competitive Overview
Regulations and Policies on Stem Cell in Malaysia
Stem Cell Funding in Malaysia
Malaysia Key Drivers Summary
Malaysia Key Restraints Summary
New Market Opportunities in Malaysia
Recent Developments in Stem Cell Research in Malaysia

22. JAPAN

Japan
Japan Stem Cell Market Overview
Timeline of Pluripotent Stem Cell Research in Japan
Regulations and Policies on Stem Cell in Japan
Stem Cell Funding in Japan
Japan Stem Cell Competitive Overview
Japan Key Drivers Summary
Japan Key Restraints Summary
Recent Developments in Stem Cell Research in Japan

23. CONCLUSION AND RECOMMENDATION

Conclusion and Recommendation
Legal Disclaimer

24. APPENDIX

Appendix
Market Engineering Methodology
List of Exhibits

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

Stem Cell Assay Market by Type, Kit, Product, Application, End User - Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, ...

Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

Stem Cell Therapies Market: By Therapy (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Stem-cell therapy medical practice which is used to treat or prevent a disease or condition using stem cells.Recent inventions and R&D activities have shown that stem cells have tremendous promise to help ...

Global Mesenchymal Stem Cells Industry

Global Mesenchymal Stem Cells Industry

  • $ 4950
  • Industry report
  • September 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Mesenchymal Stem Cells in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.